Skip to product information
1 of 3

Total p44/42 MAPK (Erk1/2) onestep ELISA Kit

Total p44/42 MAPK (Erk1/2) onestep ELISA Kit

Catalog Number: S0C3267 Reactivity: Hu; Ms; Rt; Mk Conjugation: Brand: Starter
Price:
Regular price $835 USD
Regular price Sale price $835 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Antigen Total p44/42 MAPK (Erk1/2)
Immunogen Recombinant Protein
Antibody Type Recombinant mAb
Reactivity Hu; Ms; Rt; Mk
Purification Protein A
Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8°C as supplied.

Kit


Sample type Cell culture extracts
Assay type Sandwich (quantitative)
Assay time 60 minutes
Species reactivity Hu; Ms; Rt; Mk

Background

Total p44/42 MAPK (Erk1/2) refers to the combined measurement of both phosphorylated and non-phosphorylated forms of the extracellular signal-regulated kinases 1 and 2, which are widely used as a readout of MAPK pathway activation status. Erk1 (p44) and Erk2 (p42) are closely related serine/threonine kinases that serve as the terminal components of the Ras-Raf-MEK-ERK signaling cascade. Activation of this pathway occurs through sequential phosphorylation events, culminating in MEK1/2-mediated dual phosphorylation of Erk1/2 at specific tyrosine and threonine residues, which is required for full enzymatic activity. Once activated, Erk1/2 phosphorylate hundreds of cytoplasmic and nuclear substrates, including transcription factors such as Elk and c-Fos, thereby regulating diverse cellular processes including proliferation, differentiation, survival, and migration. The "total" format detects both the active phosphorylated and inactive unphosphorylated protein pools, allowing researchers to normalize phospho-Erk signals against total Erk protein levels and thereby assess the true degree of pathway activation. Dysregulated Erk1/2 signaling is observed in approximately one-third to 40% of human cancers, making this pathway a major therapeutic target. Consequently, total p44/42 MAPK measurement is essential for characterizing signaling dynamics and evaluating the efficacy of inhibitors targeting upstream kinases such as MEK or RAF.

Picture

ELISA

Relationship between total p44/42 MAPK (Erk1/2) lysate protein concentration and absorbance in A-431 cells. The figure shows the linear relationship between protein concentration and absorbance at 450 nm (O.D. 450 nm) in lysates from untreated and EGF-treated A-431 cells. After serum starvation, A-431 cells were treated with ng/mL EGF for 5 minutes at 37°C and then lysed.

Relationship between total p44/42 MAPK (Erk1/2) lysate protein concentration and absorbance in NIH/3T3 cells. The figure shows the linear relationship between protein concentration and absorbance at 450 nm (O.D. 450 nm) in lysates from untreated and PDGF-AA-treated NIH/3T3 cells. After serum starvation, NIH/3T3 cells were treated with 100 ng/mL PDGF-AA for 20 minutes at 37°C and then lysed.

Protocol Diagram